Smoltek is getting ready for pilot production of CNF-MIM capacitors
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
Smoltek Nanotech Holding AB (publ) (“Smoltek” or “the Company”) announces that group company Smoltek Semi AB and Taiwanese Industrial Technology Research Institute (ITRI) are discussing a collaboration to set up a pilot line for fabrication of CNF-MIM capacitors in Taiwan as part of getting ready for mass production. This week Smoltek's CTO Dr. Farzan Ghavanini is on site in Taiwan for discussions on how to proceed with the project.
Smoltek Semi and ITRI have been working closely for over a year to streamline the CNF-MIM front- end-of-line (FEOL) processes for mass production of Smoltek's capacitors. In the next phase of the collaboration, the two organizations will focus on accelerating the transition from development to volume production through the implementation of a pilot line.
“As we are getting closer to introducing our CNF-MIM capacitor technology to the market, we have intensified our efforts in setting up a pilot manufacturing line close to our customers”, Smoltek's CTO Dr. Farzan Ghavanini states.
Smoltek’s CTO, Dr. Farzan Ghavanini is in Taiwan this week for meetings with ITRI’s director of Smart Sensing and Systems Technology Center, Dr. Arthur Lin, to discuss how to proceed with this project.
About ITRI
Taiwan’s Industrial Technology Research Institute (ITRI) is at the forefront of industrialization of novel semiconductor devices and components and has played a pivotal role in introducing new technologies to the market.
For further information
Håkan Persson, CEO of Smoltek Nanotech Holding AB
E-mail: hakan.persson@smoltek.com
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors
Smoltek develops new products with disruptive performance, based on nanotechnology, which solve advanced material engineering challenges in several industrial sectors. Today, the company operates in two business areas: semiconductors and hydrogen. Smoltek protects its unique carbon nanotechnology through an extensive patent portfolio consisting of more than 110 applied for patents, of which 92 are currently granted. The company's share is listed on the Spotlight Stock Market under the short name SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels are to be interpreted as forecasts and not commitments.
